We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$19.1B
AUM Growth
-$71.6M
Cap. Flow
+$375M
Cap. Flow %
1.97%
Top 10 Hldgs %
20.96%
Holding
1,713
New
9
Increased
554
Reduced
98
Closed
38

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$83.2M
2
DQ
Daqo New Energy
DQ
+$42.7M
3
DAR icon
Darling Ingredients
DAR
+$33M
4
TER icon
Teradyne
TER
+$25.8M
5
IQV icon
IQVIA
IQV
+$25.1M

Sector Composition

Rank Sector Weight
1 Technology 24.47%
2 Healthcare 17.68%
3 Consumer Discretionary 14.03%
4 Financials 13.08%
5 Industrials 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDFN
951
DELISTED
Redfin
RDFN
$912K ﹤0.01%
18,200
UFPI icon
952
UFP Industries
UFPI
$5.03B
$911K ﹤0.01%
13,395
DNLI icon
953
Denali Therapeutics
DNLI
$3.97B
$908K ﹤0.01%
18,000
CDK
954
DELISTED
CDK Global, Inc.
CDK
$907K ﹤0.01%
21,314
UHAL icon
955
U-Haul Holding Co
UHAL
$14.4B
$904K ﹤0.01%
14,000
PRFT
956
DELISTED
Perficient Inc
PRFT
$904K ﹤0.01%
7,812
+100
+1% +$10.3K
INGR icon
957
Ingredion
INGR
$6.63B
$902K ﹤0.01%
10,130
LPRO
958
DELISTED
Open Lending Corp
LPRO
$902K ﹤0.01%
25,000
WD icon
959
Walker & Dunlop
WD
$1.47B
$902K ﹤0.01%
7,951
+1,200
+18% +$126K
FATE icon
960
Fate Therapeutics
FATE
$294M
$901K ﹤0.01%
15,200
IRT icon
961
Independence Realty Trust
IRT
$4.01B
$901K ﹤0.01%
44,261
+16,300
+58% +$324K
FLNA
962
Filana Therapeutics
FLNA
$45.7M
$900K ﹤0.01%
14,500
+100
+0.7% +$8.35K
CRUS icon
963
Cirrus Logic
CRUS
$6.08B
$897K ﹤0.01%
10,895
DAVA icon
964
Endava
DAVA
$167M
$897K ﹤0.01%
6,600
+1,100
+20% +$142K
TX icon
965
Ternium
TX
$10.7B
$897K ﹤0.01%
21,200
NAVI icon
966
Navient
NAVI
$867M
$894K ﹤0.01%
45,300
+4,700
+12% +$101K
UMBF icon
967
UMB Financial
UMBF
$11.5B
$893K ﹤0.01%
9,230
ENV
968
DELISTED
ENVESTNET, INC.
ENV
$893K ﹤0.01%
11,123
HLF icon
969
Herbalife
HLF
$1.28B
$891K ﹤0.01%
21,018
DIOD icon
970
Diodes
DIOD
$4.48B
$889K ﹤0.01%
9,809
+1,600
+19% +$140K
GSAT icon
971
Globalstar
GSAT
$10.7B
$889K ﹤0.01%
35,480
+973
+3% +$23.9K
RL icon
972
Ralph Lauren
RL
$23.1B
$888K ﹤0.01%
8,000
OUT icon
973
Outfront Media
OUT
$5.24B
$884K ﹤0.01%
35,643
UBSI icon
974
United Bankshares
UBSI
$6.68B
$882K ﹤0.01%
24,246
BKU icon
975
Bankunited
BKU
$3.41B
$880K ﹤0.01%
21,032

Similar funds

Handelsbanken Fonder's Q3 2021 Portfolio in Review

As of Q3 2021, Handelsbanken Fonder held 1,713 positions worth $19.1B, down 0.37% from $19.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 2.7%. Handelsbanken Fonder opened 9 new positions and exited 38, leaving the 1,713-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Handelsbanken Fonder's largest Q3 2021 buy was Volta Inc.: 1,671,677 shares worth $14.5M.
  • Handelsbanken Fonder added most to Regeneron Pharmaceuticals in Q3 2021, an estimated $83.2M increase.
  • Handelsbanken Fonder's biggest Q3 2021 reduction was Amgen, cutting an estimated $49.3M.
  • Handelsbanken Fonder fully exited Johnson Controls International in Q3 2021, selling an estimated $19.2M.
  • Handelsbanken Fonder's ten largest holdings make up 21% of its $19.1B portfolio in Q3 2021.
  • Handelsbanken Fonder opened 9 new positions and closed 38 in Q3 2021.
  • Handelsbanken Fonder's portfolio value fell 0.37% quarter-over-quarter to $19.1B.

Based on Handelsbanken Fonder's 13F filing for Q3 2021, filed 10 Nov 2021.